Cannabis Extract Market Size & Growth Forecast 2026–2035, By Segments (Product Type, Extract Type, Sources, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Cannabis Extract Market size stood at USD 5.63 Billion in 2025 and is predicted to grow at a 19.8% CAGR from 2026 to 2035, reaching USD 34.28 Billion by 2035. The industry revenue for 2026 is calculated at USD 6.63 billion.
Get more details on this report
Request Free Sample ReportCannabis Extract Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 75.36% market share in 2025, supported by mature licensed cultivation, standardized extraction, established retail channels, and strong medical and adult-use product demand.
- Europe is projected to grow at a 22.18% CAGR, driven by expanding medical cannabis access, stronger physician acceptance, regulated supply development, and increasing demand for standardized extract formulations.
Segment Momentum
- Oils accounted for 60.92% of the market in 2025 because they provide formulation flexibility, standardized dosing, and broad compatibility across medical, wellness, and consumer product applications.
- Full Spectrum Extracts held a 67.87% share in 2025 while remaining the fastest-growing extract type due to strong demand for products retaining a broader range of plant compounds across multiple formulations.
Market Expansion Drivers
- Expansion of medical cannabis legalization supporting therapeutic extract adoption.
- Rising chronic disease burden increasing demand for cannabis-based therapies.
- Product innovation in CBD oils and tinctures expanding pharmaceutical integration.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the cannabis extract market include Canopy Growth Corporation (Canada), Tilray Brands, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cronos Group Inc. (Canada), Organigram Holdings Inc. (Canada), Tikun Olam Ltd. (Israel), Curaleaf Holdings, Inc. (United States), Green Thumb Industries Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As more jurisdictions formalize medical cannabis frameworks, the cannabis extract market benefits from a shift from informal consumption toward regulated, physician-guided therapeutic use. Legalization creates the conditions for licensed cultivation, standardized extraction, prescription pathways, and pharmacy or clinic-based distribution, which makes oils, tinctures, and other measured-dose formats more viable than smokable products in medical settings. This regulatory structure influences prescribing behavior and procurement decisions, aiding market expansion by giving healthcare providers and patients greater confidence in product consistency, cannabinoid content, and traceability.
Rising chronic disease burden increasing demand for cannabis-based therapies
The growing prevalence of chronic conditions such as persistent pain, neurological disorders, and treatment-resistant symptoms is reinforcing market demand for formulations that can be used over extended periods with dose control and administration flexibility. In the cannabis extract market, this favors extracts over raw flower because clinicians and patients often prefer products that fit repeatable therapeutic routines, especially when symptom management requires titration or combination cannabinoid profiles. Demand is shaped in practice by longer treatment journeys, ongoing symptom burden, and the search for adjunct therapies when conventional options deliver incomplete relief or create tolerability concerns.
Product innovation in CBD oils and tinctures expanding pharmaceutical integration
Advances in CBD oil and tincture formulation are supporting market development by making cannabis-derived products easier to align with pharmaceutical standards for dosing, stability, and patient usability. In the cannabis extract market, innovation is not limited to new product launches; it changes how manufacturers position extracts for clinical acceptance through improved bioavailability, more precise cannabinoid concentrations, and delivery formats suited to routine prescribing. That practical compatibility supports deeper integration into medical channels, where standardized non-inhalable products are more likely to gain attention from healthcare systems, formulary decision-makers, and companies pursuing regulated therapeutic applications.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising legalization and medical adoption of cannabis extracts | 7.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Expansion in recreational cannabis markets | 6.00% | Medium term (2–5 yrs) | Europe, Asia Pacific (spillover: North America) | Medium | Moderate |
| Technological advancements in extraction and formulation | 6.80% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Expansion of medical cannabis legalization supporting therapeutic extract adoption | 2.70% | High | North America, Europe | High | Near Term |
| Rising chronic disease burden increasing demand for cannabis-based therapies | 2.20% | High | North America, Middle East & Africa | High | Mid Term |
| Product innovation in CBD oils and tinctures expanding pharmaceutical integration | 1.90% | Moderate | North America, Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 75.36% share of the cannabis extract market in 2025, backed by a mature commercial framework in which licensed cultivation, extraction, product formulation, and retail channels are already functioning at scale. The region’s leadership is reinforced by established consumer demand across medical and adult-use applications, broader product availability, and the presence of experienced operators with the processing capacity to produce standardized extracts consistently. In practice, this allows manufacturers and distributors to move products more efficiently through regulated channels, supporting higher transaction volumes and deeper market penetration than in less-developed regional ecosystems.
Europe is projected to expand at a 22.18% CAGR over the forecast period, with growth in the cannabis extract market being propelled by the gradual widening of medical access and the steady buildout of regulated supply pathways. Momentum is being driven by increasing physician acceptance in applicable treatment settings, rising demand for standardized extract-based formulations, and stronger alignment around quality-controlled production and distribution. As regulatory pathways become more workable across parts of the region, market activity is accelerating through practical adoption patterns centered on prescribed use, import partnerships, and the expansion of compliant processing and dispensing infrastructure.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Medical Cannabis ExpansionGermany's cannabis extract market is increasingly oriented toward pharmaceutical and therapeutic applications supported by evolving healthcare acceptance. German stakeholders are emphasizing standardized extracts and quality-controlled production suitable for prescription-based medical use.
France 🇫🇷
Pharmaceutical Evaluation PathwayFrance is assessing cannabis extracts through medical and clinical frameworks, encouraging interest in standardized formulations and patient access programs. The French market is prioritizing evidence-based applications and controlled distribution mechanisms for cannabis-derived products.
Italy 🇮🇹
Specialty Extract ApplicationsItaly's cannabis extract market is supported by demand for medically oriented formulations and specialized therapeutic products. Companies in Italy are focusing on extraction quality, product consistency, and compliance with pharmaceutical-grade manufacturing requirements.
Japan 🇯🇵
Research-Oriented DevelopmentJapan remains focused on research and regulatory assessment of cannabis-derived compounds rather than broad commercial adoption. Interest in Japan is centered on extracts with potential pharmaceutical applications and scientifically validated therapeutic properties.
South Korea 🇰🇷
Controlled Therapeutic AccessSouth Korea maintains a tightly regulated environment where cannabis extracts are primarily considered for specific medical applications. Market activity in South Korea is concentrated on compliant import channels and carefully supervised therapeutic use cases.
United States 🇺🇸
Product Diversification CenterThe U.S. cannabis extract market benefits from broad product innovation across medical and wellness applications. Companies in the U.S. are expanding extraction capabilities and developing differentiated formulations, including concentrates, tinctures, and ingredient-based consumer products.
Segment Leadership and Growth Trends
Cannabis Extract Market Share (%), Product Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the cannabis extract market, Oils accounted for a 60.92% share in 2025, reflecting both their established lead and continued expansion across end-use applications. This position is sustained by the practical versatility of oils, which fit easily into medical, wellness, and consumer product formats while offering dosing flexibility and straightforward formulation. Their ongoing growth momentum in the cannabis extract market is underpinned by the same operational advantages that drive current demand, especially as producers and buyers favor extract formats that are easier to standardize, blend, and integrate into a broad range of products than many alternative formats.
Extract Type Segment Analysis: Full Spectrum Extracts (Largest & Fastest-Growing Segment)
In 2025, Full Spectrum Extracts held a 67.87% share of the cannabis extract market, making them the dominant extract type while also maintaining the strongest growth momentum. Their leadership is grounded in sustained preference for extract profiles that preserve a wider range of plant compounds, aligning with market demand for products perceived as more complete and less heavily reduced than narrower extract alternatives. Growth in the cannabis extract market continues to favor Full Spectrum Extracts because this broader compound retention supports their use across diverse formulations, helping manufacturers meet evolving product expectations without shifting away from a format already widely accepted in the market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Oils, Tinctures | Oils | Oils |
| Extract Type | Full Spectrum Extracts, Cannabis Isolates | Full Spectrum Extracts | Full Spectrum Extracts |
| Sources | Hemp, Marijuana | Marijuana | Marijuana |
| End-use | Medical Use, Recreational Use | Medical Use | Medical Use |
Competitive Landscape and Market Positioning
1. Canopy Growth Corporation (Canada)
2. Tilray Brands Inc. (Canada)
3. Aurora Cannabis Inc. (Canada)
4. Cronos Group Inc. (Canada)
5. Organigram Holdings Inc. (Canada)
6. Tikun Olam Ltd. (Israel)
7. Curaleaf Holdings Inc. (United States)
8. Green Thumb Industries Inc. (United States)
In the cannabis extract market, evolving regulatory frameworks are shaping product standardization and safety requirements. Innovation is focused on improving extraction purity and consistency. The cannabis extract market is also witnessing diversification in therapeutic and wellness applications. Research efforts are supporting improved formulation stability and efficacy.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Artrix | Apr-26 | Artrix introduced "Glassic," a specialized glass vape platform engineered for premium cannabis extracts. The hardware focuses on improving vapor purity and flavor profiles, providing manufacturers with a technical solution to enhance product performance and differentiation within the competitive cannabis extract-based vaping segment. |
| Somai Pharmaceuticals | Feb-26 | Somai Pharmaceuticals is scaling its international footprint, currently operating in 12 countries with plans to expand to 18. This multi-market strategy strengthens the company’s distribution network for regulated cannabis extracts, leveraging regional regulatory approvals and partnerships to capture market share across European and other emerging international medical cannabis sectors. |
| Vertanical | Oct-25 | Vertanical achieved Phase III clinical trial success for its VER-01 cannabis-derived therapy for chronic low back pain. This clinical milestone validates the company’s evidence-based therapeutic pipeline, significantly strengthening its regulatory standing in Europe and providing a foundation for upcoming pivotal clinical studies required for U.S. market entry. |
| Demecan | Jul-25 | Demecan launched "FE 800 No.1," the first German-produced cannabis extract utilizing live rosin extraction technology. This innovation introduces premium extraction standards to the German medical cannabis market, signaling a shift toward higher-quality, fresh-processed products within the regulated supply chain and reinforcing the company’s competitive position in the region. |
| Grön | Mar-25 | Grön expanded its portfolio with the launch of 1000mg high-dose infused chocolates across U.S. markets. This rollout reflects a strategic focus on large-format, value-oriented cannabis extract edibles, targeting high-frequency consumers and strengthening the company's competitive presence in the medical and recreational edible segments. |
| Raw Garden | Feb-25 | Raw Garden introduced the "Sprout" vape platform, which utilizes terpene-safe materials to enhance extract purity and hardware sustainability. This development highlights a commitment to improving consumption technology and product integrity, reinforcing the company's position as a premium provider within the cannabis extract hardware ecosystem. |
| Tilray Medical | Mar-24 | Tilray Medical secured regulatory approval in Portugal for its THC 5 / CBD 20 cannabis extract formulation. This authorization facilitates the commercialization of its pharmaceutical-grade products in the Portuguese medical market, strategically bolstering the company’s European cannabis portfolio and expanding its access to regulated medical patient populations. |
| Paul's Boutique | Jan-24 | Paul’s Boutique implemented automation-driven manufacturing improvements to optimize the production of cannabis extracts. By focusing on operational modernization, the company aims to enhance batch consistency and overall process efficiency, setting a benchmark for quality standardization in the production of cannabis-based products. |
| Exka Inc | May-25 | Health authorities issued a recall for Exka Inc.’s cannabis extract products in Quebec due to defective child-resistant packaging. This development underscores the stringent regulatory requirements governing cannabis distribution and highlights the operational risks manufacturers face regarding packaging compliance and supply chain safety within legal retail frameworks. |
| Cannazo India | Jul-24 | Cannazo India leveraged national media exposure to showcase its medical cannabis extract innovations targeting multiple sclerosis patients. The initiative represents a strategic move to raise product visibility and commercialize therapeutic cannabis solutions within India's nascent medical cannabis sector, signaling potential for broader consumer acceptance of extract-based medical treatments. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Cannabis Extract Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Cannabis Extract Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the cannabis extract market?
How much is the cannabis extract industry expected to grow by 2035?
How is medical cannabis legalization impacting adoption of cannabis extracts?
Why is rising chronic disease prevalence increasing demand for cannabis extracts?
Why are oils the leading product type in the cannabis extract market?
Why are full spectrum extracts growing rapidly in the cannabis extract market?
Why is North America the largest cannabis extract market?
What is contributing to the rapid growth of the cannabis extract market in Europe?
Which companies are driving growth in the cannabis extract landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Food & Beverage Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization